Literature DB >> 31329374

ICAR: endoscopic skull-base surgery.

Eric W Wang1, Adam M Zanation2, Paul A Gardner1, Theodore H Schwartz3, Jean Anderson Eloy4, Nithin D Adappa5, Martin Bettag6, Benjamin S Bleier7, Paolo Cappabianca8, Ricardo L Carrau9, Roy R Casiano10, Luigi M Cavallo8, Charles S Ebert2, Ivan H El-Sayed11, James J Evans12, Juan C Fernandez-Miranda13, Adam J Folbe14, Sebastien Froelich15, Fred Gentili16, Richard J Harvey16,17, Peter H Hwang13, John A Jane18, Daniel F Kelly19, David Kennedy5, Engelbert Knosp20, Devyani Lal21, John Y K Lee5, James K Liu4, Valerie J Lund22, James N Palmer5, Daniel M Prevedello9, Rodney J Schlosser23, Raj Sindwani24, C Arturo Solares25, Abtin Tabaee3, Charles Teo26, Parthasarathy D Thirumala1, Brian D Thorp2, Eduardo de Arnaldo Silva Vellutini27, Ian Witterick16, Bradford A Woodworth28, Peter-John Wormald29, Carl H Snyderman1.   

Abstract

BACKGROUND: Endoscopic skull-base surgery (ESBS) is employed in the management of diverse skull-base pathologies. Paralleling the increased utilization of ESBS, the literature in this field has expanded rapidly. However, the rarity of these diseases, the inherent challenges of surgical studies, and the continued learning curve in ESBS have resulted in significant variability in the quality of the literature. To consolidate and critically appraise the available literature, experts in skull-base surgery have produced the International Consensus Statement on Endoscopic Skull-Base Surgery (ICAR:ESBS).
METHODS: Using previously described methodology, topics spanning the breadth of ESBS were identified and assigned a literature review, evidence-based review or evidence-based review with recommendations format. Subsequently, each topic was written and then reviewed by skull-base surgeons in both neurosurgery and otolaryngology. Following this iterative review process, the ICAR:ESBS document was synthesized and reviewed by all authors for consensus.
RESULTS: The ICAR:ESBS document addresses the role of ESBS in primary cerebrospinal fluid (CSF) rhinorrhea, intradural tumors, benign skull-base and orbital pathology, sinonasal malignancies, and clival lesions. Additionally, specific challenges in ESBS including endoscopic reconstruction and complication management were evaluated.
CONCLUSION: A critical review of the literature in ESBS demonstrates at least the equivalency of ESBS with alternative approaches in pathologies such as CSF rhinorrhea and pituitary adenoma as well as improved reconstructive techniques in reducing CSF leaks. Evidence-based recommendations are limited in other pathologies and these significant knowledge gaps call upon the skull-base community to embrace these opportunities and collaboratively address these shortcomings.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  CSF rhinorrhea; angiofibroma; clival chordoma; craniopharyngioma; endoscopic endonasal approach; endoscopic endonasal skull-base surgery; esthesioneuroblastoma; evidence-based medicine; meningioma; nasoseptal flap reconstruction; olfactory neuroblastoma; pituitary adenoma; squamous cell carcinoma

Mesh:

Year:  2019        PMID: 31329374     DOI: 10.1002/alr.22326

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  25 in total

Review 1.  Modern endoscopic skull base neurosurgery.

Authors:  Rafael Martinez-Perez; Luis C Requena; Ricardo L Carrau; Daniel M Prevedello
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Surgery around the Orbit: How to Select an Approach.

Authors:  Davide Locatelli; Iacopo Dallan; Paolo Castelnuovo
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-21

Review 3.  [Robot-assisted head and neck surgery].

Authors:  P J Schuler; F Boehm; L R Schild; J Greve; T K Hoffmann
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

4.  Sinonasal Malignancy and Orbital Exenteration Sparing Cancer Surgery.

Authors:  Camilo Reyes; Mihir Patel; C Arturo Solares
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-20

5.  How I Do It: Endonasal transethmoidal, transcribriform approach for resection of giant olfactory groove meningioma.

Authors:  Christopher B Cutler; J Curran Henson; Jeremiah Alt; Michael Karsy
Journal:  Acta Neurochir (Wien)       Date:  2022-07-07       Impact factor: 2.216

Review 6.  Endocrinological outcomes after transcranial resection of tuberculum sellae meningiomas: a systematic review and meta-analysis.

Authors:  Rafael Martinez-Perez; Michael W Kortz; William Florez-Perdomo; Timothy H Ung; A Samy Youssef
Journal:  Neurosurg Rev       Date:  2022-02-12       Impact factor: 3.042

7.  Anatomic Considerations of Microvascular Free Tissue Transfer in Endoscopic Endonasal Skull Base Surgery.

Authors:  Leila J Mady; Thomas M Kaffenberger; Khalil Baddour; Katie Melder; Neal R Godse; Paul Gardner; Carl H Snyderman; Mario G Solari; Mark W Kubik; Eric W Wang; Shaum Sridharan
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-22

8.  The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study.

Authors:  Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

Review 9.  Malignant Sinonasal Tumors: Update on Histological and Clinical Management.

Authors:  Alessandra Bracigliano; Fabiana Tatangelo; Francesco Perri; Giuseppe Di Lorenzo; Roberto Tafuto; Alessandro Ottaiano; Ottavia Clemente; Maria Luisa Barretta; Nunzia Simona Losito; Mariachiara Santorsola; Salvatore Tafuto
Journal:  Curr Oncol       Date:  2021-07-01       Impact factor: 3.677

10.  Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients.

Authors:  Jai Deep Thakur; Alex Corlin; Regin Jay Mallari; Samantha Yawitz; Amalia Eisenberg; Walavan Sivakumar; Chester Griffiths; Ricardo L Carrau; Sarah Rettinger; Pejman Cohan; Howard Krauss; Katherine A Araque; Garni Barkhoudarian; Daniel F Kelly
Journal:  Pituitary       Date:  2021-07-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.